ENTYVIO is a biologic treatment for moderate to severe Crohn's disease (CD) or ulcerative colitis (UC). See Safety and Prescribing Information.

See ENTYVIO treatment options, infusion and subcutaneous injection, for Crohn's disease and ulcerative colitis. See Safety and Prescribing Information.

Learn how ENTYVIO, a biologic treatment, can reduce Crohn’s disease and ulcerative colitis inflammation. See Safety and Prescribing Information.

Explore common questions regarding the ENTYVIO Pen and infusion, side effects, pregnancy info, and more. See Safety and Prescribing Information.

Discover ENTYVIO resources for those who are currently on or starting their treatment journey, as well as those looking to explore patient support programs.

ENTYVIO is a biologic for adults with moderate to severe Crohn's disease or ulcerative colitis. See Safety and Prescribing Information.

In two clinical trials, ENTYVIO delivered results for adults with moderate to severe ulcerative colitis when other medicines had not worked well enough or could not be tolerated.

EntyvioConnect provides financial assistance, resources, and expert guidance to support you throughout every step of your ENTYVIO treatment journey.

See the impact of ENTYVIO (vedolizumab) in reducing symptoms and achieving remission for Crohn’s disease. See Safety and Prescribing Information.

With cost support from EntyvioConnect, eligible patients may pay as little as $5 per dose of ENTYVIO,* up to a total benefit of $20,000 per year regardless of insurance coverage and whether prescribed …